Thomas Haws Email and Phone Number
west chester, pennsylvania, united states
Thomas Haws's Location
West Chester, Pennsylvania, United States, United States
About Thomas Haws
Vice President, Program Leader with extensive experience in the fields of clinical development, clinical pharmacology, clinical operations, molecular biology, cellular biology, and assay development with 25 years of pharmaceutical experience. Experience spanning project leadership in both the biotech start-up and big pharma environment. A passionate and inclusive team leader responsible for building and managing large, cross-functional matrix teams with full accountability to senior leaders for setting and implementing long-term strategy, transitioning preclinical assets into early phase clinical studies and delivering on clinical development plans and regulatory strategy. Experienced with cross-functional matrix team leadership and have the ability to learn quickly, build/drive strategy and work across boundaries. Experienced in working with small molecules, biopharmaceutical agents, gene therapy and stem cells across a range of therapeutic areas including cardiovascular disease, wound healing, metabolic and muscular diseases, respiratory, allergy, COVID-19, and rare diseases. Looking for an opportunity to leverage my skill set in an environment that will allow for growth and development.CORE STRENGTHS- Ability to assimilate quickly into new teams and get up to speed rapidly in new therapeutic areas and novel modalities.- Leadership, management, organizational, and operational skills, attention to details, dedicated and hardworking, and a proactive problem solver. - Accountability for leading and enabling clinical matrix teams on achieving project objectives, milestones and timelines.- Outstanding interpersonal, communication (both oral and written), and negotiation skills with experience presenting to internal (matrix and executive-level management) and external partners (key opinion leaders).- Cross-therapeutic clinical development expertise. AREAS OF EXPERTISE- Clinical Development - Clinical Operations - Clinical Pharmacology- Project Management - Data Analysis - Regulatory Compliance - Efficiency Improvements
Thomas Haws's Current Company Details
Verrica Pharmaceuticals
View
Vice President, Clinical Development
west chester, pennsylvania, united states
- Website:
- verrica.com
- Employees:
- 31
Thomas Haws Work Experience Details
-
Vice President Clinical DevelopmentVerrica Pharmaceuticals Aug 2023 - PresentWest Chester, Pennsylvania, United States- Responsible for Company’s clinical programs, strategy, development, and life-cycle management in dermatological disease indications.- Develops the Clinical Development Plan in line with the Target Product Profile.- Leads and supports the clinical components of key documents (e.g., Clinical Trial Protocols, Investigator’s Brochures, Clinical Study Reports (CSRs), regulatory documents including IND/CTA and regulatory responses) with high quality and consistency with the CDP. - Collaborates with Scientific Communication of clinical data, including external messaging, publication planning and congress management. -Develops and leads KOL speaker programs on company-relevant disease states, current therapeutics, and patient care gaps.
-
Vp, Program LeaderSynlogic, Inc. May 2022 - Aug 2023Cambridge, Massachusetts, United States And West Chester, Pa- Strategic lead for PKU program team and early-stage development programs in metabolic disorders- Member on the strategic leadership team and Science and Technology Committee- Provides strategic guidance to support Clinical (Clinical Development, Clinical Operations, Biomarker), CMC, Regulatory, and Commercial teams- Responsible for leading, prioritizing and managing the multi-disciplinary team to deliver the development of the product development plan- Coordinate development of global clinical and regulatory strategy in alignment with CMC. - Highly involved in all aspects of development, from contributing to regulatory interactions and IND/CTA submissions, engagement with KOLs and patient advocacy organizations, and in market research activities. -
Executive Director, Therapeutic Development Team LeaderPassage Bio Mar 2021 - May 2022Philadelphia, Pennsylvania, United States- Therapeutic Development Team Leader for GM1 Gangliosidosis and Krabbe Disease. - Single point of accountability for the GM1 Gangliosidosis and Krabbe Disease compound development to the Passage Executive Team and Joint Steering Committee for the Passage/Penn collaboration.- Developed and lead both the compound strategy and corresponding integrated compound development plan for GM1 Gangliosidosis and Krabbe Disease.- Was responsible for leading, prioritizing and managing the multi-disciplinary teams to deliver all aspects of the GM1 Gangliosidosis and Krabbe Disease programs. - Acted as spokesperson for the GM1 Gangliosidosis and Krabbe Disease programs both internally and externally.- Provided strategic guidance to support Clinical (Clinical Development, Clinical Operations, Biomarker), CMC, Regulatory, and Commercial sub-teams.- Member of the Diversity, Equity, and Inclusion (DEI) Committee. -
Clinical Development Director In Discovery MedicineGsk Jan 2019 - Mar 2021Collegeville, Pennsylvania, United States- Discovery Medicine Leader for four assets (pre-clinical to clinical phase), targeting COVID-19, allergy, heart failure and a rare pediatric disease. - Single point of accountability for the Clinical Development Plans from Commit-to-Target to Commit-to-Phase 2.- Provided clinical development and strategic leadership to the Clinical Matrix Team (CMT) and translational and clinical input to the project beyond Commit-to-Phase-2.- Was responsible for clinical indication prioritization and sequencing on targets in the early research pipeline. - Conducted and planned First Time in Human, clinical pharmacology, and = PoC trials in adult and pediatric patients.- Was accountable for clinical input into clinical protocols, study documentation, clinical components of regulatory submissions and responses to regulatory authority questions, or questions arising from Ethic’s review.- Participated in data review ongoing through studies including dose-escalation meetings, interim analyses, in-stream data review, etc.- Prepared and presented data externally in the form of abstracts, posters, presentations for conferences.- Ability to matrix lead with the broader GSK organization, including Translational Biologists, Safety Assessment, Biomarker Group, CMC, DMPK, Late-Stage Development, VEO, and Commercial.- Experienced with interactions with regulatory agencies, key opinion leaders, patient advocacy groups, CROs, etc. to build strong clinical development plans. - Standing Member of Clinical Pharmacology and Experimental Medicine Protocol Review Forum.- Functional lead for the Integrated Resource Management Program. -
Senior Clinical Director/Clinical Team Leader In Muscle Metabolism Discovery Performance Unit (Dpu)Gsk Apr 2016 - Jan 2019King Of Prussia, Pa- Provided clinical development leadership, disease area expertise, regulatory and prescriber insight to the Discovery Performance Unit (DPU).- Created and implemented high quality clinical development plans (CDPs) and data analysis strategies that applied appropriate models and surrogate markers by delivering compelling information to inform decision making within the DPU.- Early Development Leader for Daprodustat program for rotator cuff injury. Responsible for development of the pre-clinical safety packages, CDPs, clinical study designs, clinical operations, regulatory strategies, manufacturing, and senior leader engagement.- Helped execute and shape the overall R&D strategy by working with matrix partners both internal and external to GSK.- Interfaced on behalf of GSK with key external experts and members of program-level external committees (e.g., Executive Steering Committee, and Independent Data Monitoring Committee).
-
Clinical Program Lead In Clinical Platforms & SciencesGlaxosmithkline Nov 2012 - Apr 2016Collegeville, Pennsylvania, United States- Built, led, and motivated global project and clinical teams to deliver their designated portfolios. - Supported the workload, resource requirements, operational interactions, and commitment to timelines and budget for the early stage portfolio within the Heart Failure DPU. - Authored and reviewed clinical pharmacology protocols, amendments, informed consents, clinical study reports, clinical pharmacology sections of IBs, annual IND updates, new INDs, case report form development, and designed other study related materials. - Coordinated multiple Phase I and IIa clinical studies: reviewed CRO contracts and budgets; reviewed and tracked all study related invoices; CRA training, conducted study initiation meetings, investigator meetings and KOL meetings; study center evaluation, initiation, and operational oversight on clinical conduct of studies; coordinated shipment of study drug and analysis of clinical specimens; reviewed case report forms and electronic databases; monitored clinical study data; closed out study sites; reviewed final safety listings; worked with data management to achieve final database lock.- Accountable for the execution and delivery of Clinical Pharmacology, Proof of Concept and Proof of Mechanism studies.- Ability to understand and analyze complex cross-discipline technical details with drug development- Proficient in outsourcing of clinical trials in a global environment- Proficient budget management and negotiations across various countries and vendors - Conduct studies with strict adherence to ethical and regulatory standards governing clinical research, including ICH, GCP and international regulatory guidelines, as well as company operating procedures. - Led and participated in Global teams focusing on re-engineering and simplification- Line management responsibilities including recruitment, setting objectives, driving performance, building, development plans, and coaching.
-
Principal Clinical Research Scientist In Clinical Pharmacology Science And Study OperationsGlaxosmithkline Apr 2008 - Nov 2012King Of Prussia, Pennsylvania, United States- Author and review clinical pharmacology protocols, amendments, informed consents, clinical study reports, clinical pharmacology sections of CIB and annual IND updates.- Coordinate multiple Phase I and IIa cardiovascular clinical studies: review CRO contracts and budgets; review and track all study related invoices; conduct study initiation meetings; coordinate shipment of study drug to sites; coordinate shipment, receipt and analysis of clinical specimens; review case report forms and electronic databases; monitor clinical study data; close out study sites; review final safety listings; work with data management to achieve final database lock.- Communicate with Project Team and Clinical Matrix Team members on a regular basis to give Phase I and IIa updates and offer input on clinical development plans from a Phase I/IIa perspective.
-
Senior Clinical Research Scientist In Csso, Clinical Pharmacology Discovery MedicineGlaxosmithkline Jun 2006 - Apr 2008King Of Prussia, Pennsylvania, United States- Author and review clinical pharmacology protocols, amendments, informed consents, clinical study reports, clinical pharmacology sections of CIB and annual IND updates.- Coordinate multiple Phase I cardiovascular clinical studies: review CRO contracts and budgets; review and track all study related invoices; conduct study initiation meetings; coordinate shipment of study drug to sites; coordinate shipment, receipt and analysis of clinical specimens; review case report forms and electronic databases; monitor clinical study data; close out study sites; review final safety listings; work with data management to achieve final database lock.- Communicate with Project Team and Clinical Matrix Team members on a regular basis to give Phase I updates and offer input on clinical development plans from a Phase I perspective.
-
Principal Scientist - Us Biomarker Lab, Clinical Pharmacology Discovery MedicineGlaxosmithkline Jul 2001 - Jun 2006King Of Prussia, Pennsylvania, United States- Assumed responsibility for all aspects of assigned clinical studies (review of study protocols, design of pharmacodynamic plans, interaction with KOLs, laboratory, and scientific staff to ensure project completion. - Co-Chaired the Biomarker Sub-Team to identify the appropriate biomarkers for upcoming clinical studies. - Designed, validated and conducted assays for the pharmacodynamic assessment of clinical assets by authoring SOPs and validation reports and maintained laboratory under GLP regulations.- Assumed responsibility for supervising summer interns and new hires within the US biomarker lab.
-
Township Supervisor, Westtown Board Of SupervisorsWesttown Township Jan 2012 - Jan 2017Westtown Township, Chester County, PaPositions Held - 2017- Police Commissioner, 2016- Chairman of the Board of Supervisors, 2015- Police Commissioner, 2014- Police Commissioner, 2013- Chairman of the Board of Supervisors, 2012- Vice-Chairman of the Board of Supervisors - Charged with the general governance of the township and the execution of legislative, executive and administrative powers in order to ensure sound fiscal management and to secure the health, safety and welfare of the citizens of the township. -
Staff Scientist In Applied BiotechnologyDupont Pharmaceuticals Mar 2000 - Jul 2001Wilmington, Delaware, United States- Responsible for the PCR cloning of selected novel and known genes in the fields on Cardiovascular, Cancer, CNS, and Inflammatory Diseases.- Responsible of the construction of new expression vectors that employs the Cre/Lox technology.- Responsible for the PCR-Purification and Cloning of HIV Amplicons, which support NNRTI Clinical Trials. All work is performed using GLP and GMP protocols. -
Associate ScientistRhône-Poulenc Rorer/Aventis Jun 1997 - Mar 2000Collegeville, Pennsylvania, United StatesPositions Held:Associate Scientist, Cardiovascular Biology 1999-2000Research Assistant, Cardiovascular Biology 1998-1999Ursinus College RPR Fellowship awardee in Cardiovascular Biology. 1997-1998Ursinus College RPR Fellowship awardee in Gene Medicine 1997- Independent contributions in molecular analysis of cathepsin S helped demonstrate its role in atherosclerosis. This resulted in it being accepted as a candidate target for high-throughput screening.- Adapted a low throughput secondary screening assay for cathepsin S to 96 and 384 well formats.- Isolated RNA from coronary and arterial tree material from animal models of atherosclerosis and analyzed gene expression using Northern blot analysis.- Responsible for the PCR cloning and expression of selected novel gene targets involved in atherosclerosis.- Responsible for the construction of generic expression vectors containing signal peptide and HA-, MYC-, or HIS-tag sequences for use in high throughput screnning procedures. - Responsible for the PCR cloning and expression of several chemokine receptors implicated in atherosclerosis. - Assumed responsible for the identification of novel genes in the SMAD Gene family. - Employed RT-PCR and SSCP to identify novel SMAD sequences important in Transforming Growth Factor Beta (TGF-b) signal transduction pathways.
Thomas Haws Education Details
Frequently Asked Questions about Thomas Haws
What company does Thomas Haws work for?
Thomas Haws works for Verrica Pharmaceuticals
What is Thomas Haws's role at the current company?
Thomas Haws's current role is Vice President, Clinical Development.
What schools did Thomas Haws attend?
Thomas Haws attended Temple University School Of Pharmacy, Ursinus College, Temple University.
Who are Thomas Haws's colleagues?
Thomas Haws's colleagues are Kimberly Mack, Colleen Tofani, John O'connor, Christopher D. Jones, Mba, Leslie A. Sanchez-Torres, Emma V., Rob Miller.
Not the Thomas Haws you were looking for?
-
3ihsmarkit.com, ipreo.com, silabs.com -
2gmail.com, 911wash.com1 +156130XXXXX
-
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial